-
EP3443014
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3443014
| EP3443014 - MULTI-SPECIFIC ANTIGEN-BINDING CONSTRUCTS TARGETING IMMUNOTHERAPEUTICS [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 18.11.2022 Database last updated on 22.08.2024 | |
| Former | Examination is in progress Status updated on 11.03.2022 | ||
| Former | Request for examination was made Status updated on 18.01.2019 | ||
| Former | The international publication has been made Status updated on 20.10.2017 | Most recent event Tooltip | 18.11.2022 | Application deemed to be withdrawn | published on 21.12.2022 [2022/51] | Applicant(s) | For all designated states Zymeworks Inc. Suite 800 - 114 East 4th Avenue Vancouver, BC V5T 1G4 / CA | [2022/39] |
| Former [2019/08] | For all designated states Zymeworks Inc. 540-1385 West 8th Avenue Vancouver, British Colombia V6H 3V9 / CA | Inventor(s) | 01 /
MILLS, David M. c/o Zymeworks Inc. 540 - 1385 West 8th Avenue Vancouver British Columbia V6H 3V9 / CA | [2019/08] | Representative(s) | Elkington and Fife LLP Thavies Inn House 3-4 Holborn Circus London EC1N 2HA / GB | [N/P] |
| Former [2019/08] | Care, Alison, et al Kilburn & Strode LLP Lacon London 84 Theobalds Road London WC1X 8NL / GB | Application number, filing date | 17781690.7 | 13.04.2017 | [2019/08] | WO2017CA50463 | Priority number, date | US201662323432P | 15.04.2016 Original published format: US 201662323432 P | [2019/08] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2017177337 | Date: | 19.10.2017 | Language: | EN | [2017/42] | Type: | A1 Application with search report | No.: | EP3443014 | Date: | 20.02.2019 | Language: | EN | The application published by WIPO in one of the EPO official languages on 19.10.2017 takes the place of the publication of the European patent application. | [2019/08] | Search report(s) | International search report - published on: | CA | 19.10.2017 | (Supplementary) European search report - dispatched on: | EP | 02.12.2019 | Classification | IPC: | C07K16/46, A61K35/17, A61K39/395, A61P35/00, C07K16/28, C07K16/30, C12N15/13, C12N5/0783, C12N5/10, C07K16/42 | [2020/01] | CPC: |
C07K16/28 (EP,US);
C07K16/2803 (EP,KR,US);
C07K16/468 (US);
A61K2239/29 (EP,US);
A61K2239/31 (EP,US);
A61K2239/38 (EP,US);
A61K2239/48 (EP,US);
A61K35/17 (KR);
A61K39/39558 (KR);
A61K39/4611 (EP,US);
A61K39/4631 (EP,US);
A61K39/464412 (EP,US);
A61K39/464417 (EP,US);
A61K39/464468 (EP,US);
A61P35/00 (EP,KR,US);
C07K16/2878 (EP,KR,US);
C07K16/30 (EP,KR,US);
C07K16/4208 (EP);
C07K16/4241 (US);
C07K16/44 (EP);
C12N5/0636 (EP,KR,US);
A61K2039/505 (EP,KR,US);
A61K2039/507 (EP);
C07K14/70503 (US);
C07K19/00 (US);
C07K2317/31 (EP);
C07K2317/55 (EP,KR,US);
C07K2317/569 (US);
C07K2317/622 (EP,KR,US);
C07K2319/03 (EP,KR,US);
|
| Former IPC [2019/08] | C07K16/46, A61K35/17, A61K39/395, A61P35/00, C07K16/28, C07K16/30, C12N15/13, C12N5/0783, C12N5/10 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2019/08] | Title | German: | GEGEN IMMUNTHERAPEUTIKA GERICHTETE MULTISPEZIFISCHE ANTIGENBINDENDE KONSTRUKTE | [2019/08] | English: | MULTI-SPECIFIC ANTIGEN-BINDING CONSTRUCTS TARGETING IMMUNOTHERAPEUTICS | [2019/08] | French: | CONSTRUCTIONS MULTI-SPÉCIFIQUES DE LIAISON À L'ANTIGÈNE CIBLANT DES AGENTS IMMUNOTHÉRAPEUTIQUES | [2019/08] | Entry into regional phase | 13.11.2018 | National basic fee paid | 13.11.2018 | Search fee paid | 13.11.2018 | Designation fee(s) paid | 13.11.2018 | Examination fee paid | Examination procedure | deleted | Date on which the examining division has become responsible | 14.02.2018 | Request for preliminary examination filed International Preliminary Examining Authority: CA | 13.11.2018 | Examination requested [2019/08] | 24.09.2020 | Amendment by applicant (claims and/or description) | 11.03.2022 | Despatch of a communication from the examining division (Time limit: M04) | 22.07.2022 | Application deemed to be withdrawn, date of legal effect [2022/51] | 12.08.2022 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2022/51] | Request for further processing for: | The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report | 24.09.2020 | Request for further processing filed | 24.09.2020 | Full payment received (date of receipt of payment) Request granted | 08.10.2020 | Decision despatched | The application is deemed to be withdrawn due to failure to indicate the wish to proceed further with the application | 24.09.2020 | Request for further processing filed | 24.09.2020 | Full payment received (date of receipt of payment) Request granted | 08.10.2020 | Decision despatched | Fees paid | Renewal fee | 29.04.2019 | Renewal fee patent year 03 | 27.04.2020 | Renewal fee patent year 04 | 27.04.2021 | Renewal fee patent year 05 | Penalty fee | Additional fee for renewal fee | 30.04.2022 | 06 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [A]US2013315884 (GALETTO ROMAN [FR], et al); | [A]WO2015095895 (HUTCHINSON FRED CANCER RES [US]); | [XYI]WO2015121454 (CELLECTIS [FR]); | International search | [X]WO2014190273 (UNIV TEXAS [US]); |